854171770	854171770	CD	B-NP	O
|	|	NN	I-NP	O
MHS	MHS	NN	I-NP	O
|	|	NN	I-NP	O
89506208	89506208	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
509749	509749	CD	B-NP	O
|	|	CC	I-NP	O
2/23/2001	2/23/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
dvt	dvt	NN	I-NP	O
,	,	,	O	O
pseudogout	pseudogout	IN	B-PP	O
|	|	NNP	B-NP	B-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2001	10/19/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/17/2001	6/17/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
CROGAN	CROGAN	NN	B-NP	O
,	,	,	O	O
TYRON	TYRON	NN	B-NP	O
679-70-91-5	679-70-91-5	CD	I-NP	O
Eshing	Eshing	NNP	I-NP	O
Tuc	Tuc	NNP	I-NP	O
Ny	Ny	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/10/01	10/10/01	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MAYETTE	MAYETTE	NNP	B-NP	O
,	,	,	O	O
EUSEBIO	EUSEBIO	NNP	B-NP	O
IGNACIO	IGNACIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
joint	joint	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
ALLOPURINOL	ALLOPURINOL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ATENOLOL	ATENOLOL	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

COLACE	COLACE	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HEPARIN	HEPARIN	NNP	I-NP	O
5	5	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
U	U	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
U	U	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
REG	REG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
>	>	SYM	B-NP	O
400	400	CD	I-NP	O
For	For	IN	B-PP	O
BS	BS	NN	B-NP	O
<	<	SYM	O	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
201	201	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
250	250	CD	B-NP	I-DNA
give	give	VB	B-VP	O
0	0	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
251	251	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
300	300	CD	B-NP	I-DNA
give	give	VB	B-VP	O
0	0	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
301	301	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
350	350	CD	B-NP	I-DNA
give	give	VB	B-VP	O
8	8	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
351	351	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
400	400	CD	B-NP	I-DNA
give	give	VB	B-VP	O
10	10	CD	B-NP	O
Units	Units	NNP	I-NP	O
reg	reg	NN	I-NP	O
SC	SC	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
fs	f	NNS	B-NP	O
<	<	SYM	O	O
300	300	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
check	check	NN	B-NP	B-protein
fs	f	NNS	I-NP	I-protein
bid	bid	VBD	B-VP	I-protein
OMEPRAZOLE	OMEPRAZOLE	NNP	B-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
15	15	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
5/17/01	5/17/01	CD	B-NP	O
-01	-01	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
Give	Give	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
4/29/01	4/29/01	CD	B-NP	O
-01	-01	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
Give	Give	IN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
9/4/01	9/4/01	CD	B-NP	O
-01	-01	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
--	--	:	O	O
done	do	VBN	B-VP	O
GLUCOTROL	GLUCOTROL	NNP	B-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/11	6/11	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
npo	npo	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	RB	B-NP	O
Applicable	Applicable	JJ	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Nsaid	Nsaid	NNP	B-NP	O
's	's	POS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
pseudogout	pseudogout	NN	B-NP	O
,	,	,	O	O
dvt	dvt	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
dvt	dvt	NN	I-NP	O
,	,	,	O	O
pseudogout	pseudogout	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ugib	ugib	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
duod	duod	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
second	second	JJ	B-ADJP	O
to	to	TO	B-PP	O
nsaid	nsaid	NN	B-NP	O
's	's	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
non-sustained	non-sustained	JJ	I-NP	O
v-tah	v-tah	JJ	I-NP	O
gout	gout	NN	I-NP	O
and	and	CC	I-NP	O
hyperuricemia	hyperuricemia	NN	I-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

cad	cad	NN	B-NP	O
s/p	s/p	NN	I-NP	O
chole	chole	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
periph	periph	NN	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
84	84	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
iddm	iddm	NN	I-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
ugib	ugib	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
duod	duod	NN	B-NP	O
.	.	.	O	O

ulcer	ulcer	NN	B-NP	O
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
R	R	NN	B-NP	B-protein
DVT	DVT	NN	I-NP	I-protein
and	and	CC	O	O
polyarticuar	polyarticuar	NN	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/25	10/25	CD	B-NP	O
pt	pt	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
CBMC	CBMC	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
UGIB	UGIB	NN	I-NP	B-protein
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
duod	duod	NN	B-NP	O
.	.	.	O	O

ulcer	ulcer	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
vioxx	vioxx	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
ulcer	ulcer	NN	B-NP	O
was	be	VBD	B-VP	O
cauterized	cauterize	VBN	I-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
his	his	PRP$	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
incr	incr	JJ	B-NP	O
R	R	NN	I-NP	O
knee	knee	NN	I-NP	O
and	and	CC	I-NP	O
elbow	elbow	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
fascilitiy	fascilitiy	JJ	B-ADJP	B-protein
where	where	WRB	B-ADVP	I-protein
his	his	PRP$	B-NP	I-protein
bs	b	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
difficutl	difficutl	NN	B-NP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
WGH	WGH	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Leni	Leni	NNP	B-NP	O
's	's	POS	B-NP	O
revleaed	revleae	VBN	I-NP	O
R	R	NN	I-NP	O
peroneal	peroneal	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
knee	knee	NN	I-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
for	for	IN	B-PP	O
straw	straw	JJ	B-NP	O
colored	color	VBN	I-NP	O
fluid	fluid	NN	I-NP	O
c/w	c/w	NN	I-NP	O
pseudo-gout	pseudo-gout	NN	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	O
=	=	SYM	B-VP	O
17	17	CD	B-NP	O
.	.	.	O	O

Pseudo-gout	Pseudo-gout	NN	B-NP	O
:	:	:	O	O
.	.	.	O	O

Rx	Rx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
and	and	CC	O	O
therapeutic	therapeutic	JJ	B-NP	O
tap	tap	NN	I-NP	O
of	of	IN	B-PP	O
knee	knee	NN	B-NP	O
jo	jo	NN	I-NP	O
int	int	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
minimal	minimal	JJ	B-NP	O
pain	pain	NN	I-NP	O
now	now	RB	B-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-PP	O
weight	weight	NN	B-NP	O
bear	bear	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

DVT	DVT	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
manage	manage	VB	I-VP	O
conservatively	conservatively	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
UGIB	UGIB	NN	I-NP	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
LE	LE	NN	I-NP	O
u/s	u/	NNS	I-NP	O
on	on	IN	B-PP	O
9/27	9/27	CD	B-NP	O
and	and	CC	I-NP	O
6/26	6/26	CD	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
no	no	DT	B-NP	O
extension	extension	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DVT	DVT	NN	I-NP	B-DNA
.	.	.	O	O

Treat	Treat	VB	B-VP	O
prophylactically	prophylactically	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
heparin	heparin	NN	I-NP	O
sc	sc	NN	I-NP	O
,	,	,	O	O
pneumoboot	pneumoboot	NN	B-NP	O
to	to	TO	B-VP	O
lle	lle	VB	I-VP	O
.	.	.	O	O

DM	DM	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Jayson	Jayson	NNP	I-NP	O
Verville	Verville	NNP	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
elevated	elevate	VBN	I-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
managed	manage	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
nph	nph	NN	B-NP	O
and	and	CC	I-NP	O
czi	czi	NN	I-NP	O
ss	ss	NN	I-NP	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
oral	oral	JJ	I-NP	O
agent	agent	NN	I-NP	O
of	of	IN	B-PP	O
Glucotrol	Glucotrol	NN	B-NP	B-protein
XL	XL	NN	I-NP	I-protein
was	be	VBD	B-VP	O
re-started	re-started	JJ	B-NP	O
and	and	CC	I-NP	O
supplemented	supplement	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
am	am	NN	I-NP	O
nph	nph	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
glucophage	glucophage	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
insufficency	insufficency	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
creatnine	creatnine	NN	I-NP	O
=	=	SYM	B-VP	O
1.3	1.3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	O
sx	sx	NN	I-NP	O
's	's	POS	B-NP	O
-	-	HYPH	I-NP	O
Ua	Ua	NN	I-NP	O
wnl	wnl	NN	I-NP	O
,	,	,	O	O
uculture	uculture	NN	B-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
DVT	DVT	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
managed	manage	VBN	I-VP	O
w/out	w/out	IN	B-PP	O
anti-coagulation	anti-coagulation	JJ	B-NP	O
secondary	secondary	JJ	I-NP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
UGIB	UGIB	NN	I-NP	O
.	.	.	O	O

Serial	Serial	JJ	B-NP	O
u/s	u/	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
no	no	DT	B-NP	O
extension	extension	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

If	If	IN	B-SBAR	O
pt	pt	NN	B-NP	O
.	.	.	O	O

ambulating	ambulate	VBG	B-VP	O
w/o	w/o	AFX	B-NP	O
ut	ut	JJ	I-NP	O
incr	incr	NN	I-NP	O
LE	LE	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
additional	additional	JJ	B-NP	O
LE	LE	NN	I-NP	O
u/s	u/	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
here	here	RB	B-ADVP	O
which	which	WDT	B-NP	O
affected	affect	VBD	B-VP	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VANDYNE	VANDYNE	NNP	B-NP	O
,	,	,	O	O
MARVIN	MARVIN	NNP	B-NP	O
MIGUEL	MIGUEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MX62	MX62	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/10/01	10/10/01	CD	I-NP	O
@	@	SYM	B-NP	O
08	08	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

